Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3.
Zhang W, Fan Z, Wang F, Yin L, Wu J, Li D, Song S, Wang X, Tang Y, Huang C.
Zhang W, et al. Among authors: wang x, wang f.
Oxid Med Cell Longev. 2023 Jan 14;2023:9966355. doi: 10.1155/2023/9966355. eCollection 2023.
Oxid Med Cell Longev. 2023.
PMID: 36691640
Free PMC article.